EDT.TO/ Spectral medical

[CoachCB]

Year high is 42 cents US..it's nothing but is around a 20% premium from todays price...of 34 cents
I think this pushes the year high shortly...if not you've got something promising in the medium run.


I bought a tad today.

I'm in at .33 (average).

 

[Bozzie]

I'm in at .33 (average).

You check out that new investor presentation CB?
They call it something like a 6.5 billion dollar market between the two devises....Baxter has to be interested in the the whole company and both parts IMO..EDTs pump is a better machine, cheaper to build and has more functions and is going for home approval now in the US, its better than anything Baxter has in its aging and not well selling line. Baxter also has a filter for endotoxin but it hasn't performed well..or as least it looks that way given the investment partnership with Spectral on their filter.

I'm going to listen today at 4 PM this finally has PR behind it..PR works in bio and Pharma this company has always been misunderstood and like sepsis itself ...sorta in the shadows, I'm always chipping about the Pump but the filter is big too.

I've held this long than I'd ever like to admit..sold out twice once in 08 to buy a house with cash and another time after losing some obscene amount of paper $ in oct of 2016 on poor FDA news( think it was around 1.70 and slid to 26 cents in a hour..I have+ 500k shares of this..worst morning ever and i had a meeting that day early...Bumbled hard on my presentation a didn't win the account..I thought I was going to retire be able to tell these people I'd pass on the job....hurts to even think about it all and I'm not shitting.
Reason I bought back In 2017 was the post havoc numbers found in the meta analysis were great ,the price and Trumps HD initiative.

its been a long road I don't mind holding but this one tested every oz of patience I've had at given points.
I think I'll win eventually my bet is unreasonable in reality..I know it..it's still a penny stock on a shit market.

Beware this has tons of risk I know you know that CB just saying it again for anyone else thinking of stepping in.

 

[CoachCB]

You check out that new investor presentation CB?
They call it something like a 6.5 billion dollar market between the two devises....Baxter has to be interested in the the whole company and both parts IMO..EDTs pump is a better machine, cheaper to build and has more functions and is going for home approval now in the US, its better than anything Baxter has in its aging and not well selling line. Baxter also has a filter for endotoxin but it hasn't performed well..or as least it looks that way given the investment partnership with Spectral on their filter.

I'm going to listen today at 4 PM this finally has PR behind it..PR works in bio and Pharma this company has always been misunderstood and like sepsis itself ...sorta in the shadows, I'm always chipping about the Pump but the filter is big too.

I've held this long than I'd ever like to admit..sold out twice once in 08 to buy a house with cash and another time after losing some obscene amount of paper $ in oct of 2016 on poor FDA news( think it was around 1.70 and slid to 26 cents in a hour..I have+ 500k shares of this..worst morning ever and i had a meeting that day early...Bumbled hard on my presentation a didn't win the account..I thought I was going to retire be able to tell these people I'd pass on the job....hurts to even think about it all and I'm not shitting.
Reason I bought back In 2017 was the post havoc numbers found in the meta analysis were great ,the price and Trumps HD initiative.

its been a long road I don't mind holding but this one tested every oz of patience I've had at given points.
I think I'll win eventually my bet is unreasonable in reality..I know it..it's still a penny stock on a shit market.

Beware this has tons of risk I know you know that CB just saying it again for anyone else thinking of stepping in.

Wow, that's big hit!! You have 500K shares of this? I'm at 10,000+. I want to see it make a run and I'll dump it.

 

[Bozzie]

Wow, that's big hit!! You have 500K shares of this? I'm at 10,000+. I want to see it make a run and I'll dump it.

yeah...Way too much and good plan hope this bumps up a little here.

Presentation in 1/2 an hour.

 

[Bozzie]

3 Docs from Paradigm Capital with price targets of 4 dollars

Google drive link

https://drive.google.com/drive/folders/1JhPNYMcQDZWBL_Tn8Qc65YquNduMzOoh?usp=sharing

 

[CoachCB]

3 Docs from Paradigm Capital with price targets of 4 dollars

Google drive link

https://drive.google.com/drive/folders/1JhPNYMcQDZWBL_Tn8Qc65YquNduMzOoh?usp=sharing

Holy Sh*t!!

 

[Bozzie]

Holy Sh*t!!

Never know but it's nice to see after all this time.

This JP Morgan conference coming up is were things started with Baxter..This year Dialco will get some heat I'd think.

Good luck short term dude.

 

[Bozzie]

Not bad if you listened CB, I've heard this before but it's tightening up as a message...
I like it, CFO Chris Seto's a smart dude.... I have a good amount of hope despite the risk.

 

[CoachCB]

Not bad if you listened CB, I've heard this before but it's tightening up as a message...
I like it, CFO Chris Seto's a smart dude.... I have a good amount of hope despite the risk.

Didn't listen, was working then hit the gym.

 

[Bozzie]

Nice move today..last week they did a JPM investor conference, it's the same conference that they made a deal with Baxter last year.

Up 18% today and still a screaming deal..with a good amount of risk..

Don't follow here unless you can deal with long ugly roads witch this has been and never buy this on up days its had selloff's on the regular after decent days...at some point that will change but I don't trust this move yet.

 

[Bozzie]

Darker markets have been seeing action as well and that's unusual ..The volume on the TSX isn't the whole story lately.
The US side isn't factored in either in the daily volume.

Stockwatch.com is a good resource

T:EDT - SPECTRAL MEDICAL INC - http://www.spectraldx.com

11:41:53 EST

Sym-X	Bid - Ask	Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
EDT - T ▲ATS	5.0	0.47	·	0.48	48.0	0.48	+0.04	9.1	178.6	83	111	0.445 0.51 0.435	0.81 0.345	11:22:11	Jan 11	15 min RT 2¢
TSX - T	5.0	0.47	·	0.48	48.0	0.47	+0.03	6.8	110.9	51	49	0.445 0.50 0.435	0.81 0.345	11:14:03		15 min
NEO ATS - U		0.495	+0.055	12.5	41.0	19	28	0.445 0.50 0.445		11:03:49		15 min
Alpha - A		0.485	+0.045	10.2	9.0	4	6	0.485 0.495 0.47		11:17:19		15 min
CX2 - H		0.48	+0.04	9.1	15.5	8	10	0.465 0.51 0.465		11:22:11		15 min
CXD - D		0.44			0.3	0	3			Dec 08 15:50:01		15 min
TriAct - M		0.44			1.9	1	15			Sep 11 14:53:46		15 min

 

[Bozzie]

Yep nice little move CB

People are speculating this is being driven to the 60 cent range for a financing....Makes some sense actually as the last round was done at the .61 level, funding or splitting the pump off as another Co. is a real possibility IMO....
If it keeps moving Monday I'll be a buyer for a short hold of some amount till around the 60 cent area then sell the part I bought and continue the long hold on the remaining position.
60 cents would be around a 30% premium as it stands today...Worth watching next week.

Done for the day..enjoy your Sunday fellas[/QUOTE


I still think this is being driven to a sale of some sorta % at around 60 cents..Financing, basically toward the eventual sale or up listing.
It'll be driven to some price then executed would be my guess....
Who knows but it's the next logical step here and nothing is getting done at 48 cents.

Going fishing enjoy the day....

 

[Bozzie]

Outset Medical currently has a market cap of 2.4 billion. So Dialco at 700mm would be less than a third of Outsets valuation ( around 3 bucks PS). I'd say that is a very conservative value to put on Dialco. Outset has home approval and we are a year away from home approval. Discounting Dialco by two thirds to make up for us still needing time for home approval is more than fair and if anything I'm over-discounting Dialco. If the FDA agrees to our protocol of 6 months for human factors testing, then this will help clarify that our approval timeline is potentially this year. That would help out a lot. Now I'm done with this for a bit.

 

[Bozzie]

Unusual volume today...860 k with the US side normal and up 22% today
Not a big deal but interesting, doing JPM and coming away looking like a winner the past two years is a very hopeful sign not something a true "Penny" stock company participates in or even gets invited to present ...No Bullshitting here I think this is ligit finally.

T:EDT - SPECTRAL MEDICAL INC - http://www.spectraldx.com

17:16:12 EST

Sym-X	Bid - Ask	Last	Chg	%Ch	Vol	$Vol	#Tr	Open-Hi-Lo	Year Hi-Lo	Last Tr	News	Delay
EDT - T ▲ATS	10.5	0.52	·	0.54	21.5	0.54	+0.10	22.7	747.4	371	303	0.445 0.54 0.435	0.81 0.345	15:59:02	Jan 11	15 min RT 2¢
TSX - T	10.5	0.52	·	0.54	21.5	0.54	+0.10	22.7	402.8	199	132	0.445 0.54 0.435	0.81 0.345	15:59:02		15 min
NEO ATS - U		0.53	+0.09	20.5	154.5	76	74	0.445 0.53 0.445		15:48:08		15 min
Alpha - A		0.52	+0.08	18.2	110.3	55	20	0.485 0.53 0.46		15:55:53		15 min
Omega - O		0.53	+0.09	20.5	23.5	12	8	0.47 0.53 0.47		15:48:08		15 min
CX2 - H		0.54	+0.10	22.7	50.6	25	23	0.465 0.54 0.465		15:59:02		15 min
CXD - D		0.44			0.6	0	5			Dec 08 15:50:01		15 min
TriAct - M		0.44			5.2	3	41			Sep 11 14:53:46		15 min

Trade times are ET. News times are ET. Bid/ask/vol sizes in thousands. NOTE: Delayed ATS trade data is included - click System Status for more information

Hide ATS · Fundamentals · Holders · Trade Workstation · Market Depth · 3 Month Closes · Technical Charts 1 yr | 3 yr | 5 yr | 10 yr | 15 yr | 20 yr · Live Charts 1 yr | 1 day · Company · Participants · 1yr Bulletins · Sedar · Historical · Options · Shorts · Portfolio

 

[Bozzie]

​I don't think EDT can be traded on Robinhood because it's on the TMX....The odd lots to me are more pricing tools being pulled. Weird and another illustration of the fallacy of messing with under capitalized markets.


From a buddy.

"Tons of tiny trades today. Especially at the open. Trades of 16 shares, 150 shares, 37 shares etc. There were 40 different odd lot trades just at the open. Way more than normal. Tons of them. I think that Robinhood theory from yesterday might be right. I don't know what got those youngins looking at us but something did. Maybe a newsletter recommendation or tweet or something else from a millennial trader/influencer. I checked stocktwits but couldn't find anything. I also checked Reddit and nothing. Somebody is talking up spectral to the young people I think".

 

[CoachCB]

I'm sittin' on 12k shares of this...ready to watch it shoot up!!

 

[Bozzie]

Spectral Medical Appoints Dr. John Kellum as Chief Medical Officer A World Authority in Blood Purification and Renal Replacement Therapy TORONTO, CANADA — February 1, 2021 – Spectral Medical Inc.(“Spectral” or the “Company”) (TSX: EDT), a late stage theranostic company advancing therapeutic options for sepsis and septic shock, as well as commercializing a new proprietary platform targeting the renal replacement therapy market through its wholly owned subsidiary Dialco Medical Inc. (“Dialco”), today announced the appointment of Dr. John Kellum, MD, MCCM as Chief Medical Officer. Dr. Kellum’s appointment is effective March 1, 2021. He will assume the full-time role of Chief Medical Officer at both Spectral and Dialco, where he will be responsible for leading all medical and scientific activities, clinical activities and scientific evaluation of all partnership opportunities. Dr. Kellum is considered one of the leading critical care researchers and world’s foremost experts on blood purification and acute kidney injury (“AKI”). He has pioneered research in the area of blood purification and has published original work on its application to clinical practice. Dr. Kellum is a founding member and past president of the Acute Dialysis Quality Initiative (ADQI) where he developed the first widely accepted consensus definition for acute renal failure - the original manuscript has been cited over 6,000 times. He is also a co-chair of the Kidney Diseases Improving Global Outcomes (KDIGO) clinical practice guideline on acute kidney injury. His research has received continuous funding from the National Institutes of Health since 2001. In addition, Dr. Kellum has served as a consultant to the FDA, the Department of Defense, the medical device industry and the pharmaceutical sector. At the University of Pittsburgh, Dr. Kellum is a Professor of Medicine, Bioengineering, and Clinical & Translational Science, and serves as a Chair in Critical Research. He is also Vice Chair for Research within the Department of Critical Care Medicine and Director of the Center for Critical Care Nephrology. He has authored more than 400 publications. He lectures widely and has given more than 300 seminars and invited lectures worldwide related to his research. “We are honored that Dr. Kellum has agreed to serve as our Chief Medical Officer,” stated Dr. Paul Walker, President and CEO of Spectral Medical Inc. “As one of the preeminent critical care researchers in the world in the field of sepsis, we expect he will be invaluable in helping complete our Tigris pivotal trial of PMX (Toraymyxin™ PMX-20R) for the treatment of patients with septic shock and endotoxemia, proven by an elevated endotoxin activity assay (“EAA”). The appointment of such a highly accomplished and respected clinician will be integral to the next phase of our growth as we move forward with our goal of combatting sepsis with our personalized therapeutic approach. Dr. Kellum’s international leadership in the critical role of directed renal replacement therapy will help guide the commercial rollout of our new “SAMI” and “DIMI” platforms targeting both the acute and chronic renal dialysis therapy markets. Given his unique capabilities and relationships, Dr. Kellum will also assist us in exploring new strategic opportunities, which could include partnerships, grants or opportunistic acquisitions of complementary assets and therapies in the fields of septic shock and acute kidney disease.” “I am very pleased to join the Spectral and Dialco teams,” said Dr. John Kellum. “Their combined diagnostic and therapeutic approach to the treatment of septic shock is unique and I believe this represents the most likely pathway to success. This approach to personalized medicine is also applicable in many other disease processes and can lead to improved patient outcomes. I look forward to helping bring new approaches to renal replacement therapy, both in the intensive care units as well as in-home. Dialco’s instrumentation offers distinctive advantages for both acute and chronic renal failure and the opportunity to improve the lives of a large number of patients.” About Spectral Spectral is a Phase III company seeking U.S. FDA approval for its unique product for the treatment of patients with septic shock, Toraymyxin™ (“PMX”). PMX is a therapeutic hemoperfusion device that removes endotoxin, which can cause sepsis, from the bloodstream and is guided by the Company’s Endotoxin Activity Assay (EAA™), the only FDA cleared diagnostic for the risk of developing sepsis. PMX is approved for therapeutic use in Japan and Europe, and has been used safely and effectively on more than 200,000 patients to date. In March 2009, Spectral obtained the exclusive development and commercial rights in the U.S. for PMX, and in November 2010, signed an exclusive distribution agreement for this product in Canada. Approximately 330,000 patients are diagnosed with severe sepsis and septic shock in North America each year. Spectral, through its wholly owned subsidiary, Dialco Medical Inc., is also commercializing a new proprietary platform, “SAMI”, targeting the renal replacement therapy (“RRT”) market. Dialco is also seeking regulatory approval for in-home use of “DIMI” which is based on the same RRT platform, but will be intended for home hemodialysis use. “DIMI” recently received its FDA 510k clearance for use in hospital and clinical settings. Spectral is listed on the Toronto Stock Exchange under the symbol EDT. ​

 

[Bozzie]

Kellum is a big deal in the world of Hemo..Maybe the biggest next to one Italian guy "Ronco" who's also been pro Spectral
He's a catch and I'd bet more changes at the top structure of the company will be coming soon...All very good signs

 

[Steiner69eR]

Added a bit more this morning (treat to average up instead of average down, as per, LOL).
Everything I am reading says this is a great catch.
We need this story to mirror that of IPA.V.
Momentum building...

 

[Bozzie]

Added a bit more this morning (treat to average up instead of average down, as per, LOL).
Everything I am reading says this is a great catch.
We need this story to mirror that of IPA.V.
Momentum building...

I think more changes are coming that will be viewed as very positive at the top of the company.
I feel as good about this as I have in a long while...

Kellum is an absolute catch he'll open doors this company couldn't even knock on a few months ago.

Today .42 cents/ 10X is very doable here


Hang tight 69er and CB